Moreover, the high glucose-6-phosphatase activity in the tissues of highly differentiated hepatocellular carcinoma can dephosphorylate the phosphorylated 18F-FDG, resulting in low 18F-FDG uptake in PET/CT, leading to false negatives (Sun et al., 2009). This evidence concerns the gene G6PC1 and hepatocellular carcinoma.